U.S. Stock News

NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Is It Too Late To Consider Qorvo (QRVO) After Its Recent Share Price Rebound?

Investors may be wondering if Qorvo at around US$88.97 is still offering value, or if most of the upside has already been priced in. The stock has had a mixed run, with a 22.9% return over the last year, a 14.4% gain over the past month and a 5.6% decline over the last week. Over five years, the return sits at a 46.7% loss. Recent price moves sit against a backdrop of ongoing interest in semiconductor stocks generally, as investors reassess which companies could benefit most from demand for...
NYSE:SES
NYSE:SESElectrical

SES AI Shifts Toward Defense And Storage With New Contracts And AI

SES AI (NYSE:SES) has converted its South Korea facility to produce NDAA-compliant drone battery cells for defense customers. The company signed a multi-year, $20 million distribution agreement with ATG EPower for North American energy storage systems. SES AI is applying AI tools to optimize defense-focused battery products, expanding its use of the technology beyond R&D. SES AI, trading at about $0.921 per share, is shifting focus beyond long-cycle EV battery development toward products...
NYSE:DELL
NYSE:DELLTech

How Dell’s Pangea 5 Supercomputer Deal Shapes Its AI Infrastructure Story

Dell Technologies (NYSE:DELL) has agreed to work with TotalEnergies and NVIDIA on Pangea 5, a next generation high performance supercomputer. The project focuses on large scale, AI driven computing infrastructure for energy, research, and advanced analytics use cases. Pangea 5 is designed with energy efficient architecture aimed at supporting complex industrial and scientific workloads. For readers tracking NYSE:DELL, this contract highlights the company’s role in supplying core...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Catalyst FIRDAPSE Deal Extends Exclusivity To 2035 And Shapes Angelini Bid

Catalyst Pharmaceuticals (NasdaqCM:CPRX) has settled all pending FIRDAPSE patent litigation with Hetero Labs. The agreement prevents Hetero from launching a generic FIRDAPSE product in the U.S. before January 2035. The settlement secures extended U.S. market exclusivity for FIRDAPSE and removes a key legal overhang for Catalyst. Catalyst Pharmaceuticals focuses on treatments for rare neurological diseases, with FIRDAPSE as its lead commercial product. In that context, the settlement with...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is It Time To Rethink Kraft Heinz (KHC) After Its Recent Share Price Slide

If you are wondering whether Kraft Heinz is a bargain or a value trap at around US$23.66, this article breaks down what that price really implies for you. The stock has recently returned 4.4% over the last week and 2.1% over the last month, yet is still showing a 3.0% decline year to date and an 11.7% decline over the past year. Recent coverage has focused on Kraft Heinz as a mature packaged food giant that investors often look to for stability, which can attract attention when prices move...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Is It Too Late To Consider Microsoft (MSFT) After The Recent Share Price Rebound?

Wondering if Microsoft at around US$420.92 is still a reasonable entry or if the value story has already played out? This article is built to help you frame that question clearly. The stock has seen short term moves, with returns of 3.2% over the last 7 days and 13.1% over the last 30 days, set against a year to date return of an 11.0% decline and a 1 year return of a 3.2% decline, while the 3 year and 5 year returns sit at 38.9% and 80.5% respectively. Recent news coverage has focused on...
NYSE:AGL
NYSE:AGLHealthcare

Is It Too Late To Consider Agilon Health (AGL) After Its Recent 260% Rally?

Wondering whether agilon health’s recent action has left the stock looking expensive or still potentially mispriced? This article breaks down what the current price might be implying about its value. The stock last closed at US$60.66, with returns of 117.0% over 7 days, 265.6% over 30 days and 260.2% year to date. The 1 year and 3 year returns stand at negative 24.6% and negative 90.4% respectively. These sharp moves are drawing attention back to agilon health, especially as investors weigh...
NYSE:ALV
NYSE:ALVAuto Components

Did Autoliv’s (ALV) Türkiye Exit and EMEA Shift Just Redefine Its Manufacturing Strategy?

Autoliv, Inc. recently announced that it will gradually discontinue its manufacturing operations in Türkiye by the first half of 2028, shifting production of airbags, seatbelts, and steering wheels to other EMEA facilities and recording an estimated US$142.00 million in related pre-tax charges. This move to consolidate capacity, while retaining customer-facing functions in Türkiye and affecting about 2,200 employees, marks a significant reshaping of Autoliv’s European production footprint...
NYSE:STT
NYSE:STTCapital Markets

Is It Too Late To Consider State Street (STT) After A 62.6% One Year Surge?

Wondering if State Street stock still offers value after a strong run, or if most of the opportunity is already reflected in the price? This article focuses squarely on what you are paying for each dollar of fundamentals. At a recent close of US$148.78, the stock has returned 13.4% over the past month, 15.3% year to date, and 62.6% over the last year, with a 2.7% decline in the last week and longer term 3 year and 5 year returns of 142.5% and 103.6%. Recent headlines around large financial...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Assessing Astronics (ATRO) Valuation After Analyst Upgrades And A Push Toward Its 52-Week High

Why Astronics Stock Is Back in Focus Astronics (ATRO) is back on investors’ radar after a strong price trend, supported by positive earnings estimate revisions and favorable analyst opinions. The stock is now trading close to its 52-week high. See our latest analysis for Astronics. The recent momentum is clear, with a 7-day share price return of 9.17% and a year to date share price return of 37.70%. The 1-year total shareholder return is very large, and the 3-year total shareholder return is...
NYSE:KTB
NYSE:KTBLuxury

A Look At Kontoor Brands (KTB) Valuation After Recent Share Price Momentum

Why Kontoor Brands is on investors’ radar Kontoor Brands (KTB) has drawn attention after a period of solid share price performance, with the stock’s gains over the past month and past 3 months prompting closer scrutiny from investors. See our latest analysis for Kontoor Brands. At a share price of $78.07, Kontoor Brands has recently shown strong momentum, with a 30-day share price return of 15.64% and a three year total shareholder return of 114.17%, highlighting how recent strength fits into...
NYSE:TPR
NYSE:TPRLuxury

Is Tapestry’s (TPR) Coach‑Led Strength And Buybacks Quietly Redefining Its Long‑Term Playbook?

Tapestry, Inc. has already reported its fiscal third-quarter 2026 results, with net sales rising to US$1,920.6 million and net income reaching US$343.8 million, alongside affirming a US$0.40 per-share quarterly dividend and completing US$811.35 million of share repurchases under its current buyback. The quarter highlighted especially strong growth at Coach and in regions such as Greater China and Europe, even as Kate Spade weakened, underscoring how brand and geographic mix are shaping...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio-Techne (TECH): Do Steady Dividends Amid Soft Sales Reveal Its True Capital Allocation Priorities?

Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and diluted EPS from continuing operations increased to US$0.32. Alongside softer demand from emerging biotech customers and shipment timing issues that weighed on revenue, Bio-Techne’s profitability improved and the Board affirmed a quarterly cash dividend of US$0.08 per share, highlighting an ongoing...
NYSE:BG
NYSE:BGFood

Is It Too Late To Consider Bunge Global (BG) After Its Strong 1 Year Rally?

Wondering if Bunge Global is reasonably priced after a strong run, or if the stock might already reflect a lot of good news? This article focuses squarely on what you are paying versus what you might be getting. The stock most recently closed at US$123.75, with a 33.6% year to date return and a 67.3% return over 1 year, following a 2.6% decline over both the last 7 days and the last 30 days. Recent coverage has highlighted Bunge Global's role in the global food and agriculture supply chain,...
NYSE:GXO
NYSE:GXOLogistics

Is It Time To Reassess GXO Logistics (GXO) After Recent Share Price Pullback?

Wondering if GXO Logistics at around US$51.88 is offering you value right now, or if the recent price action has already reflected most of the upside? The stock has pulled back, with a 9.2% decline over the last week and a 2.6% decline over the last month, while the 1 year return sits at 30.6% and the 3 year return at a 4.9% decline. Recent coverage has focused on how GXO Logistics fits into broader logistics and supply chain themes, as investors reassess the sector after a strong 1 year...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

Does TransMedics (TMDX) Revenue Growth And OCS Adoption Clarify Or Complicate Its Profitability Path?

In early May 2026, TransMedics Group reported first-quarter revenue of US$173.93 million, up from US$143.54 million a year earlier, while net income decreased to US$7.32 million as spending rose, and it reiterated full-year 2026 revenue guidance of US$727 million to US$757 million. A key development was the adoption of TransMedics’ Organ Care System Heart at the Montreal Heart Institute and CHU Sainte-Justine, highlighting expanding clinical use of its transplant technology in real-world...
NYSE:TSN
NYSE:TSNFood

Tyson Foods Faces Antitrust Scrutiny And Evolving Beef Segment Risks

U.S. federal antitrust investigators are examining beef industry practices involving Tyson Foods and other large processors. The probe focuses on potential collusion, price-fixing, and market allocation among the four largest U.S. beef processors. Authorities are also considering national security concerns linked to foreign ownership among key industry players. The investigation comes at a time when Tyson Foods (NYSE:TSN) is trading at $67.94, with the stock up 6.0% over the past week and...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Assessing FuboTV (FUBO) Valuation After A Prolonged Share Price Slump

How FuboTV Stock Has Been Performing FuboTV (FUBO) has followed a volatile path recently, with the stock up 3.5% over the past day but showing declines over the past week, month, past 3 months, year to date, and past year. The company operates a live TV streaming platform focused on sports, news, and entertainment. It currently has a market value of about US$1.1b and last closed at US$10.79 per share. See our latest analysis for FuboTV. That 3.5% daily share price gain comes after a much...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

A Look At Talen Energy (TLN) Valuation After Strong Q1 2026 Profit Recovery And Updated Outlook

Talen Energy (TLN) stock was in focus after the company reported a return to profitability in Q1 2026, beating earnings and revenue estimates, reaffirming guidance, and outlining a positive multi year outlook. See our latest analysis for Talen Energy. The stock has been volatile around the earnings release, with a 1 day share price return of a 4.74% decline and a 7 day share price return of a 4.87% gain. However, a 1 year total shareholder return of 70.84% suggests longer term momentum has...
NYSE:WK
NYSE:WKSoftware

How Q1 Profitability, In-Line Guidance and Auditor Switch Could Shape Workiva (WK) Investors’ Outlook

In early May 2026, Workiva Inc. reported first-quarter revenue of US$247.31 million, up from US$206.28 million a year earlier, and moved from a US$21.37 million net loss to a US$19 million net profit. The company also issued guidance calling for Q2 2026 revenue of US$250 million to US$252 million and full-year 2026 revenue of US$1.04 billion at the midpoint, while announcing a transition from Ernst & Young to Grant Thornton as its independent auditor without any reported disputes. Next,...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

A Look At Limbach Holdings (LMB) Valuation After Q1 2026 Earnings And Guidance Reaffirmation

Limbach Holdings (LMB) is in focus after its Q1 2026 report showed sales of US$138.86 million, net income of US$4.38 million and reaffirmed full year revenue guidance of US$730 million to US$760 million. See our latest analysis for Limbach Holdings. The share price has pulled back sharply in the very short term, with a 7 day share price return of a 25.7% decline and a 1 year total shareholder return of a 38.19% decline, even after very large 3 and 5 year total shareholder gains. This suggests...
NYSE:JLL
NYSE:JLLReal Estate

Does Strong Q1 Results And Completed Buyback Shift The Bull Case For Jones Lang LaSalle (JLL)?

In the first quarter ended March 31, 2026, Jones Lang LaSalle reported higher sales of US$6,386.5 million and net income of US$159.0 million, while also completing a long-running US$1.70 billion share repurchase program and arranging major hotel sale and financing transactions in Florida. Together, the stronger quarterly results, sizable buybacks, and high-profile hospitality financing deals underline how JLL is leaning on fee-based advisory strength and capital allocation to reshape its...
NYSE:RH
NYSE:RHSpecialty Retail

Rising Cost Headwinds And Retail Sell-Off Could Be A Game Changer For RH (RH)

In early May 2026, RH was caught in a broad sell-off affecting specialty retailers as rising oil, gasoline, and freight costs raised concerns about consumer discretionary spending and retailer margins ahead of the back-to-school season. The pressure on RH highlights how macroeconomic cost headwinds, rather than company-specific developments, can quickly reshape sentiment toward higher-end discretionary brands. We’ll now examine how this sector-wide cost pressure and consumer spending concern...